Autolus Therapeutics plc (FRA:6A3A)

Autolus Therapeutics Revenue

Autolus Therapeutics had revenue of $21.19M USD in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $51.13M, up 406.67% year-over-year. In the year 2024, Autolus Therapeutics had annual revenue of $10.12M with 496.00% growth.

• Revenue (ttm): $51.13M
• Revenue Growth: +406.67%
• P/S Ratio: 7.04
• Revenue / Employee: $78.66K
• Employees: 650
• Market Cap: 306.90M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	10.12M	8.42M	496.00%
Dec 31, 2023	1.70M	-4.66M	-73.30%
Dec 31, 2022	6.36M	4.03M	172.96%
Dec 31, 2021	2.33M	615.00K	35.86%
Dec 31, 2020	1.72M	-1.19M	-41.02%